Overview

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Status:
Completed

Trial end date:
2003-02-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to show that risperidone (an antipsychotic medication) combined with lorazepam (an anti-anxiety medication) is more effective than conventional therapy administered by intramuscular injection for emergency treatment of patients with schizophrenia.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen Pharmaceutica N.V., Belgium

Treatments:

Lorazepam
Risperidone